The nation of Zimbabwe has declined a significant American health deal worth 367 million US dollars (£272m) over five years due to the United States' request for confidential data.
The decision was revealed following a internal memorandum from December was leaked, indicating that Head of State Emmerson Mnangagwa felt the agreement was "unbalanced".
An official representative later clarified that the United States was seeking health data for scientific study and profit but was unwilling to guarantee the resulting advantages from any future treatments.
"We will now turn to the difficult and regrettable task of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had furnished over $1.9bn as health assistance to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has appealed for continued dialogue to find a agreement agreeable to all parties so the nation's critical HIV treatment initiative can continue.
Broader Implications
This rejection comes after a similar case in Kenya, where a court halted a related health funding agreement after legal challenges were filed about the safety of citizens' health data.
After resuming office last year, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
The agency had overseen assistance for the US government, but Trump stated its spending was "inefficient" and his government was pursuing government-to-government deals to boost openness and responsibility.
According to statements, 16 nations in Africa have to date signed these new health pacts, representing over $18.3bn in new funding.
Details of the Declined Deal
The money for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this cooperation would have delivered extraordinary benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently on antiretroviral therapy via American-funded initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".
"Our nation was requested to provide its genetic material and health information for a long time, without any corresponding promise of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.
"Put simply, our nation would supply the basic resources for scientific discovery without any certainty that the resulting innovations would be available to our people should a future health crisis emerge."
National Interest and International Frameworks
Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting structures already established through the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage future global health emergencies.
"This system is intended to ensure that when a nation contributes its samples, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised solely by those with the capability to develop them."
The government's concerns regarding the US deal "must not be interpreted as opposition to America," he added.
"We welcome ongoing discussions with our American counterparts on how future co-operation might be designed in a way that respects the sovereignty and dignity of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the official position, but urged that talks need to persist since much of the country's HIV programmes relied on external financing.
"Where technical issues exist, such as those involving data governance or agreement terms, these can frequently be resolved through technical clarification and mutually agreed protections," it said.
The halted deal underscores the ongoing challenges between accepting much-needed foreign assistance and protecting a country's data in an increasingly interconnected world.